TCDAQ — Tricida Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Tricida Q1 Loss Per Share $0.90
Brief: Tricida Prices 5.6 Mln Shares At Public Offering Price Of $36/Shr
Tricida: On the rise ahead of equity raise to fund kidney disease drug
Brief: Tricida Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-PVH Corp, Accenture, Nielsen Holdings, Verizon Communications, Lululemon Athletica
Tricida: Jumps on upbeat data from kidney disease drug study
Brief: Tricida Announces Positive Results From Long-Term Clinical Trial Of TRC101 In Patients With CKD And Metabolic Acidosis
Brief: Tricida Announces $200 Million Debt Facility With Hercules Capital
Brief: Tricida Reports Q4 Loss Per Share $0.66
Brief: Tricida Q3 Loss Per Share $0.71
Brief: Tricida - Co, Hercules Capital, Others, Entered Into Second Amendment
Brief: Tricida Inc - QTRLY Net Loss Per Share, Basic And Diluted $10.89
Brief: Longitude Capital Partners II Reports 7.2 Pct Stake In Tricida As Of July 2
Tricida: Surges in market debut
Brief: Tricida Shares Open At $25 In Debut On The Nasdaq, About 32 Percent Above IPO Price
NASDAQ RESUMED
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE
Brief: SAExploration To Acquire Assets Of Geokinetics Out Of Bankruptcy
Brief: Tricida Announces Initial Public Offering 11.7 Mln Common Shares Priced At $19 Per Share